Adjunctive Thymosin Beta-4 Treatment Influences M Effector Cell Function to Improve Disease Outcome in Pseudomonas aeruginosa-Induced Keratitis
Weight loss can lower TSH levels, potentially reducing your need for levothyroxine
On April 1, 2026 the FDA approved Foundayo (orforglipron), a once-daily small-molecule, non-peptide GLP-1 receptor agonist for adults with obesity or with overweight and weight-related medical problems
J Clin Chem Clin Biochem 1989
Biological Activity BPC-157 promotes wound healing, tendon and ligament repair, and has demonstrated gastroprotective and neuroprotective effects in animal models
It may mean the pace of escalation is too aggressive, the patients nutrition is not keeping up, or constipation and hydration need to be addressed first